Optiscan completes beta phase telepathology development
Confocal microscopy manufacturer Optiscan Imaging has completed the beta phase development of its cloud-connected telepathology platform developed in partnership with Prolucid Technologies. The development is a significant advancement in digital pathology, according to the company, enabling real-time, remote collaboration on patient imaging sessions. The platform utilises Optiscan’s confocal imaging technology to generate digital pathology data,…
